Herbs (Global Traditional) · Traditional Chinese Medicine
Eleuthero (Eleutherococcus senticosus) (Eleutherococcus senticosus)
Strong Evidencebotanical
Hermetica Superfood Encyclopedia
Eleuthero (Eleutherococcus senticosus) contains eleutherosides B and E as primary bioactive compounds that support stress adaptation through hypothalamic-pituitary-adrenal axis modulation. This adaptogenic herb enhances physical endurance and may reduce respiratory infection frequency based on Soviet-era clinical trials.
Eleuthero (Eleutherococcus senticosus), also known as Siberian ginseng, is a deciduous shrub native to Northeast Asia including Russia, China, Korea, and Japan, belonging to the Araliaceae family. The root is harvested, dried, and extracted using water or ethanol to produce tinctures, extracts, or powders, with European Medicines Agency approval for asthenia treatment.
Clinical evidence primarily consists of pre-1991 USSR trials summarized in narrative reviews, which showed benefits for cognitive function, endurance, and infection prevention but lacked modern RCT standards and PMIDs. A 2013 RCT (n=144) testing 120 mg/day root extract for chronic stress-related asthenia found no significant group differences in primary outcomes. Reviews note high heterogeneity, low quality, and poor standardization prevent firm efficacy assessment.
Clinically studied doses include 120 mg/day of root extract for 8 weeks. Traditional USSR trials used liquid extracts (1-2 mL/day tincture or 2-8 mL/day root extract), powders (0.5-2 g/day), or tablets (200-400 mg/day) for 2-6 weeks. Standardization typically targets 0.8-2% eleutheroside E content. Consult a healthcare provider before starting any new supplement.
Eleuthero root is not consumed as a macronutrient source; it is used as a medicinal herb/adaptogen. Its value lies entirely in its bioactive compound profile. **Key bioactive compounds (eleutherosides):** • Eleutheroside B (syringin): typically 0.05–0.15% of dried root weight; a phenylpropanoid glycoside considered a primary marker compound for quality standardization. • Eleutheroside E (syringaresinol diglucoside): typically 0.02–0.08% of dried root; a lignan glycoside, the other principal marker compound; often co-quantified with eleutheroside B for pharmacopeial compliance. • Eleutheroside A (daucosterol): a β-sitosterol glycoside present in smaller quantities. • Eleutherosides C, D, F, G: present in trace to minor amounts; include coumarins (isofraxidin glucoside), lignans, and triterpene saponins. **Other bioactive constituents:** • Phenolic acids and hydroxycinnamic acid derivatives (chlorogenic acid, caffeic acid): variable concentrations, contributing antioxidant activity. • Polysaccharides (heteroglycans, glucans): approximately 2–8% of dried root depending on extraction; shown to have immunomodulatory properties in vitro. • Triterpene saponins (ciwujianosides): minor but pharmacologically relevant; contribute to anti-inflammatory and adaptogenic effects. • Lignans (sesamin, syringaresinol free form): trace amounts beyond eleutheroside E. • Isofraxidin (a coumarin): present in small amounts; associated with anti-inflammatory activity. • β-sitosterol (free form): trace amounts alongside glycosidic form. **Minerals & vitamins:** Not a significant source; trace amounts of iron, manganese, zinc, and B-vitamins may be present in whole root preparations but are not clinically meaningful at typical dosing (300–1200 mg dried root extract per day or 2–3 mL liquid extract). **Macronutrients per typical dose:** Negligible calories, protein, fat, and carbohydrate at standard doses. Fiber content of whole dried root is moderate (~10–15% crude fiber) but irrelevant at medicinal doses. **Bioavailability notes:** Eleutheroside B (syringin) is relatively well absorbed orally and has been detected in plasma after oral dosing in pharmacokinetic studies. Eleutheroside E has moderate oral bioavailability; it undergoes hepatic metabolism and enterohepatic circulation. Polysaccharides are poorly absorbed intact but may exert immunomodulatory effects via gut-associated lymphoid tissue (GALT) and modulation of gut microbiota. Standardized extracts are typically standardized to ≥0.8–1.0% total eleutherosides (B + E combined) per pharmacopeial and commercial standards. Alcohol-based (ethanol/water) extracts generally yield higher eleutheroside concentrations than aqueous decoctions.
Eleuthero's eleutherosides B and E modulate the hypothalamic-pituitary-adrenal (HPA) axis by reducing cortisol release and enhancing adrenal function. These compounds also influence nitric oxide pathways and beta-endorphin production, supporting cardiovascular function and stress tolerance. The eleutherosides appear to work through multiple receptor systems including GABA and dopamine pathways.
Soviet-era studies from 1960-1990 involving over 2,100 subjects showed eleuthero reduced respiratory infections by 40% and improved physical work capacity. However, these trials lacked modern randomized controlled trial standards and proper placebo controls. A 2004 RCT with 20 elderly subjects found no significant cognitive improvements compared to placebo. Most existing evidence comes from non-peer reviewed Soviet research with methodological limitations.
Eleuthero is generally well-tolerated with mild side effects including insomnia, irritability, and elevated blood pressure in sensitive individuals. It may interact with digoxin by falsely elevating serum levels and can potentiate anticoagulant medications. The herb should be avoided during pregnancy and breastfeeding due to insufficient safety data. Individuals with autoimmune conditions should use caution as eleuthero may stimulate immune system activity.
